cancer inhibitors trang 2 tải miễn phí từ TAILIEUCHUNG

"cancer inhibitors" trang 2 - tải miễn phí từ Tailieuchung

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triplenegative breast cancer: A systematic review and meta-analysis

Immune checkpoint inhibitors plus neoadjuvant chemotherapy in early triplenegative breast cancer: A systematic review and meta-analysis

10 45 1

Checkpoint inhibitors in metastatic gastric and GEJ cancer: A multi-institutional retrospective analysis of real-world data in a Western cohort

Checkpoint inhibitors in metastatic gastric and GEJ cancer: A multi-institutional retrospective analysis of real-world data in a Western cohort

10 29 3

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: A retrospective study

Efficacy and safety of maintenance immune checkpoint inhibitors with or without pemetrexed in advanced non-squamous non-small cell lung cancer: A retrospective study

9 17 1

Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: A retrospective cohort study

Use of computed tomography-derived body composition to determine the prognosis of patients with primary liver cancer treated with immune checkpoint inhibitors: A retrospective cohort study

10 8 1

Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

Update of a prognostic survival model in head and neck squamous cell carcinoma patients treated with immune checkpoint inhibitors using an expansion cohort

10 12 1

Aromatase inhibitors and risk of cardiovascular events in breast cancer patients: A systematic review and metaanalysis

Aromatase inhibitors and risk of cardiovascular events in breast cancer patients: A systematic review and metaanalysis

11 60 0

Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells

Plocabulin, a novel tubulin-binding agent, inhibits angiogenesis by modulation of microtubule dynamics in endothelial cells

13 54 1

Current status of the clinical use of PD-1/ PD-L1 inhibitors: A questionnaire survey of oncologists in China

Current status of the clinical use of PD-1/ PD-L1 inhibitors: A questionnaire survey of oncologists in China

7 42 1

Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells

Krüppel-like factor 9 and histone deacetylase inhibitors synergistically induce cell death in glioblastoma stem-like cells

13 62 1

MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib

MK-2206 sensitizes BRCA-deficient epithelial ovarian adenocarcinoma to cisplatin and olaparib

12 30 1

5α-reductase inhibitors impact prognosis of urothelial carcinoma

5α-reductase inhibitors impact prognosis of urothelial carcinoma

7 25 1

Questionnaire-based detection of immunerelated adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

Questionnaire-based detection of immunerelated adverse events in cancer patients treated with PD-1/PD-L1 immune checkpoint inhibitors

10 32 1

Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems

Immune checkpoint inhibitors-related myocarditis in patients with cancer: An analysis of international spontaneous reporting systems

9 28 1

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: A retrospective study

The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: A retrospective study

17 48 1

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

The impact of the tumor shrinkage by initial EGFR inhibitors according to the detection of EGFR-T790M mutation in patients with non-small cell lung cancer harboring EGFR mutations

6 84 0

Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement

Comparison of detection methods and follow-up study on the tyrosine kinase inhibitors therapy in non-small cell lung cancer patients with ROS1 fusion rearrangement

12 64 1

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer

Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer

13 14 1

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer

Dual targeting of FGFR3 and ERBB3 enhances the efficacy of FGFR inhibitors in FGFR3 fusion-driven bladder cancer

11 8 1

Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: A case report

Positive response to Icotinib in metastatic lung adenocarcinoma with acquiring EGFR Leu792H mutation after AZD9291 treatment: A case report

6 32 1

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

Therapeutic implications of PD-L1 expression in bladder cancer with squamous differentiation

10 59 0

Đầu
1
[ 2 ]
3
4
5
6
7
8
9
10
11
12
13
14
Cuối

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.